Dr. David B. Samadi is bringing Medical Information to the People

Dr. David B. Samadi was born in Iran and grew up in the Jewish Community of Persia. Samadi and his brother Peter left Iran in 1979 following the Iranian Revolution when David was 15 years old. They went to Belgium and then London before venturing to the United States. He completed his secondary school education in Roslyn, New York. He decided on a career in medicine and attended Stony Brook University on a full scholarship and earned a Biochemistry degree. He attended medical school and in 1994 he graduated with a Doctor of Medicine (MD) degree from S.U.N.Y., Stony Brook School of Medicine, Stony Brook, New York. Samadi completed training in the field of urology from the Montefiore Medical Center and also received proctology training while at Albert Einstein College of Medicine in 1996. He undertook a fellowship in oncology while at Memorial Sloan Kettering Cancer Center completing the program in 2001. In 2002, he undertook a fellowship in robotic prostatectomy at France’s Henri Mondor Hospital.

Dr. Samadi is currently the Robotic Surgery Chief and Chair of Urology at Lenox Hospital. He is a certified urologist through board registration with training in the treatment for urologic diseases, bladder, kidney and prostate cancer. His focus is in invasive treatments for prostate cancer and includes laparoscopic radical prostatectomy.

He began his practice of medicine at Columbia Presbyterian Hospital and in 2007; he took on challenges with Mt. Sinai School of Medicine and became the Chair of the Department of Urology and the Chief of Robotic and minimally Invasive Surgery. Samadi invented the SMART technique (Samadi Modified Advanced Robotic Treatment) and has used the technique on more than 6,000 prostate cancer patients. He has a 90% cancer free rate with the technique. The SMART technique was developed to replace open surgery with an alternate method that is minimally invasive and utilizing the da Vinci robotic system.

Dr. Samadi has received a number of awards including being named Best Doctor by New York Magazine for the years 2009 through 2015, one of America’s Top Doctor for Cancer, the Patients Choice Award, the Community Partner Award by the American Cancer Society and the Top Doctor award from Castle Connolly.

Dr. Samadi hosts Sunday Housecall via Internet livestream. He addresses the latest in medical care the popular medical topics of discussion. He will often interview medical professionals on a variety of topics and seek out professionals to help to better inform people on medical matters.

Dr. Samadi’s  Facebook Page: www.facebook.com/DrDavidSamadi/

The Revolutionist, Eric Lefkofsky; the Genius Behind Cancer Medicine

Cancer is arguably one of the leading causes of death in the whole world. A recent study reveals, about 39.6 adults will get a cancer diagnosis at some point in their life. New cases get reported in Africa, Asia, and South America. With most of these cases leading to untimely death. However, there is a ray of hope at the end of the tunnel for cancer patients.

Tempus, a technology-based company, is dedicated to deliver the best treatment to cancer patients, as well as, offer accurate diagnosis of the diseases. It is by examining their molecular data, that is, it’s genomic sequencing and curbs it in its earlier stages. How does Tempus work? I’ll explain.

Tempus, Co-founded by Eric Lefkofsky of the Groupon Company is determined to deliver treatment to cancer patients using technology. Lefkofsky got thrust into cancer research when his wife got diagnosed with breast cancer. He could not understand why information collected from cancer patients was treated casually, yet it was a goldmine to determine the exact cause of cancer and provide its cure.

Tempus was born as a platform to analyze a cancer patient clinical information and molecular data accurately. Lefkofsky and his team developed an analytical software that would help gather clinical and medical information of cancer patients. Initially, this was their biggest problem, because most of this information was usually in the form of the physician notes.

Later, they also developed a software that was to help transform acquired data into clearly structured text. Through the processing of the natural languages and optical recognition. It resulted in the availability of relevant notes on a patient that could be used to propel cancer research and treatment to advancement.

Eric Paul Lefkofsky, the brain behind Tempus, was born on 2nd of September 1969 in Detroit Michigan. He refers to himself as an entrepreneur and a professor. He is the co-founder and CEO of Tempus, co-founder, and chairman of Groupon.

He graduated in the University of Michigan with Jurisdiction Degree. Despite his academic credentials, he didn’t go into law; instead, he chose the technology way. Apart from being an entrepreneur, Lefkofsky is a professor. He has taught in De Paul University Kellstadt Graduate School of Business.

About Eric Lefkofsky: lefkofskyfoundation.com/about-eric-lefkofsky/ 

Eric Lefkofsky’s Education And Business Ventures

Eric Lefkofsky is an American entrepreneur who is most noted as the co-founder and chairman of the popular e-commerce website Groupon. He grew up in Michigan where he attended school and eventually went on to earn a degree. Continue reading to learn more about Eric Lefkofsky’s educational background as well as his many different business endeavors.


Eric Lefkofsky began his educational career at the Southfield-Lathrup High School back in 1983. The school was located in Lathrup, Michigan close to his childhood home. He graduated from high school in 1987 before moving on to college.

Eric Lefkofsky attended the University of Michigan which is one of the most popular schools in the country and is located in Ann Arbor, Michigan. They currently have over 40,000 students and are known for their many amazing sports teams. Lefkofsky graduated from the University of Michigan in 1991 with high honors.

After attending and graduating from the University of Michigan Eric Lefkofsky then went on to continue his education at the University of Michigan law school also located in Ann Arbor, Michigan. The school was established cancer resource in 1859 and offers some of the top programs in the world. Eric Lefkofsky graduated from the University of Michigan law school in 1993 after receiving his Juris doctor. A Juris doctor also known as a doctor of jurisprudence is a graduate entry professional degree in law and one of many different doctor of law degrees.

Business Endeavors

Eric Lefkofsky has been involved in many different health care business endeavors over the years. These are just a few of the many titles and roles he has held since graduating from the University of Michigan law school.

Co-founder and chairman of Groupon

Groupon is a very popular eCommerce website that currently has millions of subscribers in many different countries all over the world in the following: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html click here.

Co-founder and CEO of Tempus

Tempus is a unique and innovative approach to cancer. It is a technology company that is helping to build the world’s largest library of molecular and clinical data. It is a new and improved way of offering personalized care to each individual patient using genetic coding and other technology advanced data.

Co-founder of LightBank

Lightbank is a financial organization that has specialties in making venture capital investments. They were founded in 2010 and are headquartered in Chicago, Illinois.

These are just a few of the many different business endeavors that Eric Lefkofsky has been involved in over the years. He’s also heavily involved in many different charities and is constantly working to improve the world.

What Makes Cancer Treatment Centers of America Unique

When many people come to Cancer Treatment Centers of America® (CTCA), they are looking for a solution that meets their unique needs. CTCA is a specialized health care company that operates with a philosophy that each patient is unique, and deserves a comprehensive approach to their treatment, that takes not only their own unique health issues in mind but also relies on the most recent cancer treatment data.

That’s why CTCA has partnered with NantHealth and Allscripts to create a custom solution while helping eviti®, another NantHealth clinical decision support solution, to access clinical workflows in the Allscripts Sunrise electronic health record.

What does this mean in a practical, everyday sense? Treatment decisions will come faster. The Clinical Pathways program helps inform the cancer treatment process, without interrupting the physician’s clinical workflow, providing a clinical decision support solution that is both practical and cutting-edge.

The project to improve the workflow came from a practical source as well: A network of hundreds of oncologists across the US. The direct interface of the clinical operating system (NantOS) was crowds ourced and built with their input. With this expertise, Cancer Treatment Centers of America has access to a comprehensive collection of cancer data to use for critical clinical decisions. Click here to learn more about CTCA.

Every cancer is as unique as the person fighting it, and that’s why fighting cancer requires truly personalized care, delivered by experts trained in the complexities of a difficult disease. This data will help doctors at CTCA continue to offer the best medical care to their clients, based on the most recent data in the field.

For further information follow CTCA on Facebook.